Here are three things to know.
1. The FDA approved the drug under the President’s Emergency Plan for AIDS Relief, a federal initiative to combat the global HIV/AIDS epidemic.
2. TLE400 will be used as a first-line treatment regimen for HIV/AIDS patients in developing countries.
3. The World Health Organization recommended the drug as an alternative first-line treatment for HIV-positive adults in 2016.
More articles on supply chain:
96% of older Americans want Medicare to negotiate drug costs: 4 survey findings
FDA granted 99% of applications for access to unapproved drugs in FY 2016
FDA warns of safety risks with Abbott’s dissolving stent: 5 takeaways
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
